Trump Cuts South Africa's HIV Lifeline

Trump Cuts South Africa's HIV Lifeline Over Afrikaner Claims

US ends $400m PEPFAR aid, citing "Afrikaner persecution" — ignoring public health urgency of nation's 8 million HIV cases

The Trump administration has begun withdrawing PEPFAR funding from South Africa, cutting off approximately $400 million annually in HIV/AIDS support, according to the BBC, Semafor, and The Kenya Times. A State Department official told reporters the decision stems from "South Africa's failure to make demonstrable progress on policy requests by the administration" — not epidemiological need, but political demands tied to President Trump's false claims of "white genocide."

The real leverage here is geopolitical. Congressional aides told Semafor that the administration's conditions include demands South Africa reduce ties with Iran, end Black Economic Empowerment policies, and cease what Trump calls the "Kill the Boer" chant. None of these have anything to do with HIV. The health department simply became the pressure point in a broader clash over South Africa's economic transformation, international alignment, and refusal to bend on charges it considers historically baseless — apartheid-era inequality justifies modern affirmative action, Pretoria argues.

The Gap South Africa Cannot Close

Until January 2025, PEPFAR covered roughly one-fifth of South Africa's HIV budget. The country now hosts 8 million people living with HIV — more than anywhere else on Earth — and has only begun compensating. South Africa's own health ministry provided $46 million in emergency response: 11.5 percent of what was lost. A $115 million bridge plan that ran through March temporarily filled the void, but Semafor reported that as of June 2026, South Africa has received only $25 million for HIV efforts this year.

The drawdown affects not armchair economics but clinic operations. The Treatment Action Campaign laid off 101 of its 189 staff when Pepfar terminated overnight. Mobile testing units, prevention programs targeting sex workers and men who have sex with men, and mother-to-child transmission prevention collapsed. The Desmond Tutu Health Foundation projects the cuts could result in as many as half a million deaths.

South Africa's own research capacity will also hemorrhage. Wits RHI, a global leader in HIV science, depends partly on U.S. funding. According to BBC reporting, the cuts themselves have defunded data collection — so officials do not know how many people are defaulting from treatment or whether new infections are rising. The epidemic's trajectory after June 2026 is now invisible.

What Comes Next

The Trump administration plans to close PEPFAR entirely in South Africa by early 2027, according to Semafor's reporting from congressional aides. U.S. Ambassador Leo Brent Bozell III was expected to meet South Africa's health ministry in late June to confirm the timeline. South Africa's government has signaled it will not capitulate on Black Economic Empowerment or foreign policy to restore funding — Health Minister Aaron Motsoaledi told the BBC there is "no chance of them going back."

Watch whether the Global Fund and other bilateral donors can close the gap. Semafor reported that South Africa has secured 900,000 doses of lenacapavir through the Global Fund, but that covers 450,000 people — a fraction of the need for both treatment and prevention in a population where 180,000 new infections occurred last year. The next critical date is South Africa's budget announcement, where Motsoaledi has signaled intentions to increase domestic spending. Without it, and without a policy reversal in Washington, clinics will continue to close and treatment disruption will begin driving drug resistance.

Sources: BBC: US to end Pepfar funding of South Africa's HIV programmes | Semafor: Trump administration to end PEPFAR funding for South Africa | The Kenya Times: South Africa Faces HIV Funding Cut As Trump Administration Moves To End PEPFAR Support | BBC: US aid cuts send South Africa's HIV treatment 'off a cliff' *